Literature DB >> 19772276

Retinal vasculopathy in Fanconi anemia.

Shu-Ming Chai1, Ranjana Mathur, Sze-Guan Ong.   

Abstract

The authors present a case of Fanconi anemia with bilateral rapid onset retinal neovascularization and vitreous hemorrhage. The patient developed branch retinal vein occlusion in the left eye complicated by vitreous hemorrhage and was treated conservatively with intravitreal hyaluronidase injection. He declined vitrectomy and his visual acuity deteriorated to no perception of light. On follow-up, the right eye was noted to have clinical and angiographic evidence of sheathed vessels, an isolated large frond of neovascularization associated with areas of capillary nonperfusion. Panretinal photocoagulation and vitrectomy were performed with stabilization of vasculopathy and visual acuity. This case illustrates rapid onset peripheral occlusive vasculopathy with an atypical large isolated frond of neovascularization in a patient with Fanconi anemia resulting in blindness in one eye. Patients with Fanconi anemia would benefit from close and regular ophthalmological review. Copyright 2009, SLACK Incorporated.

Entities:  

Mesh:

Year:  2009        PMID: 19772276     DOI: 10.3928/15428877-20090901-11

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  3 in total

1.  Possibility of enhanced risk of retinal neovascularization in repeated blood donors: blood donation and retinal alteration.

Authors:  Reza Rastmanesh
Journal:  Int J Gen Med       Date:  2011-09-06

Review 2.  Ocular manifestations of idiopathic aplastic anemia: retrospective study and literature review.

Authors:  Ahmad M Mansour; Jong Wook Lee; Seung Ah Yahng; Kyu Seop Kim; Maha Shahin; Nelson Hamerschlak; Rubens N Belfort; Shree K Kurup
Journal:  Clin Ophthalmol       Date:  2014-04-17

Review 3.  Revesz syndrome revisited.

Authors:  Michael Karremann; Eva Neumaier-Probst; Frank Schlichtenbrede; Fabian Beier; Tim H Brümmendorf; Friedrich W Cremer; Peter Bader; Matthias Dürken
Journal:  Orphanet J Rare Dis       Date:  2020-10-23       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.